2026 Seattle Cellular Therapy Summit conference hero image

2026 Seattle Cellular Therapy Summit

Accreditation: 13.25 Nursing Contact Hours | 13.25 ABIM MOC II | 13.25 AMA PRA Category 1 Credit™ | 13.25 ACPE Pharmacy

Venue: Bell Harbor International Conference Center , 2211 Alaskan Way, Seattle, WA, United States

Start Date: End Date:
Register for Conference

Official conference page for 2026 Seattle Cellular Therapy Summit.

About 2026 Seattle Cellular Therapy Summit

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Hitomi Hosoya
Yucai Wang
35+

Faculty and committee

Our Speakers

Faculty

Mazyar Shadman

Mazyar Shadman, MD

Session Chair

Fred Hutch Cancer Center/University of Washington

Binay Shah

Binay Shah, MD, MHA

Session Chair

Natalie Wuliji

Natalie Wuliji, DO

Session Chair

Fred Hutch Cancer Center

Lawrence Fong

Lawrence Fong, MD

Session Chair

Fred Hutch Cancer Center

Filippo Milano

Filippo Milano, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Alexey Danilov

Alexey Danilov, MD

Session Chair

City of Hope

Folashade Otegbeye

Folashade Otegbeye, MPH, MBBCh

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Krish Patel

Krish Patel

Session Chair

Nirav Shah

Nirav N Shah, MD

Session Chair

Medical College of Wisconsin

Rahul Banerjee

Rahul Banerjee, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Jordan Gauthier

Jordan Gauthier, MD, Other

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Alan Skarbnik

Alan Skarbnik, MD

Session Chair

Director, Lymphoma and CLL Program and Immune Effector Cell Therapeutics Program, Novant Health Cancer Institute

Hany Elmariah

Hany Elmariah

Topic Presenter

Ryan Cassaday

Ryan Cassaday, MD

Topic Presenter

University of Washington & Fred Hutch Cancer Center

Mengyang Di

Mengyang Di, MD, PhD

Topic Presenter

University of Washington/Fred Hutch Cancer Center

Andrew Cowan

Andrew Cowan, MD

Topic Presenter

BC Cancer Agency

Soheil Meshinchi

Soheil Meshinchi

Topic Presenter

Sid Devarakonda

Sid Devarakonda, MD

Topic Presenter

Lara Davis

Lara E. Davis, MD

Topic Presenter

Fred Hutchinson Cancer Center

Saurabh Dahiya

Saurabh Dahiya, MD

Topic Presenter

Stanford University

Hans-Peter Kiem

Hans-Peter Kiem, PhD

Topic Presenter

Fred Hutchinson Cancer Center (FHCC)

Bita   Fakhri

Bita Fakhri, MD, MPH

Topic Presenter

Max Julve

Max Julve

Topic Presenter

Nilanjan Ghosh

Nilanjan Ghosh, MD

Topic Presenter

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine

Sibel Blau

Sibel Blau, MD

Topic Presenter

Northwest Medical Specialties, PLLC

Matthew Lunning

Matthew Alexander Lunning, DO

Topic Presenter

University of Nebraska Medical Center

Soni Smith

Soni Smith

Topic Presenter

Brian Hill

Brian Hill, MD, PhD

Topic Presenter

Cleveland Clini

Paolo Strati

Paolo Strati, MD

Topic Presenter

The University of Texas MD Anderson Cancer Center

Murali Janakiram

Murali Janakiram, MD

Topic Presenter

CITY OF HOPE

Hitomi Hosoya

Hitomi Hosoya, MD PhD

Topic Presenter

Yucai Wang

Yucai Wang, MD PhD, MD PhD

Topic Presenter

Mayo clinic

Conference program and agenda

Our Agenda

Day 1: Friday, August 14th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

08:00 AM - 09:15 AMRegistration, Breakfast, & Exhibits
09:15 AM - 09:30 AMWelcome & Opening Remarks
09:30 AM - 09:45 AMBinaytara's Efforts in Improving Cancer Care Disparities
09:45 AM - 11:15 AMSolid Tumors I

Session Chair: Lawrence Fong, MD

09:45 AM - 10:00 AM

Immuno-oncology for GU Malignancies Lawrence Fong, MD

10:00 AM - 10:15 AM

Lung Cancer: Tarlatamab Sid Devarakonda, MD

10:15 AM - 10:30 AM

Malignant Melanoma: Lifileucel and Beyond Max Julve

10:30 AM - 10:45 AM

Immunotherapy for Sarcoma Lara E. Davis, MD

10:45 AM - 11:15 AM

Panel Discussion

Moderators:

Lawrence Fong, MD

Panelists:

Sid Devarakonda, MD; Max Julve ; Lara E. Davis, MD

11:15 AM - 12:15 PMSolid Tumors II

Session Chair: Folashade Otegbeye, MBBCh, MPH

11:15 AM - 11:30 AM

Novel FOLR1 CAR-T Therapy Soheil Meshinchi

11:30 AM - 11:45 AM

FACT Standards for Immune Effector Cells in the Community Setting Folashade Otegbeye, MBBCh, MPH

11:45 AM - 12:15 PM

Panel Discussion

Moderators:

Folashade Otegbeye, MBBCh, MPH

Panelists:

Soheil Meshinchi

12:15 PM - 01:15 PMLunch & Exhibits
01:15 PM - 02:30 PMCAR-T Cells — The Next Breakthroughs

Session Chair: Natalie Wuliji, DO

01:15 PM - 01:30 PM

Multispecific CAR-T — Will They Change Our Standard of Care? Saurabh Dahiya, MD

01:30 PM - 01:45 PM

In-Vivo CAR-T Platforms Hans-Peter Kiem, PhD

01:45 PM - 02:00 PM

CAR-T Therapy for Autoimmune Disorders Natalie Wuliji, DO

02:00 PM - 02:30 PM

Panel Discussion

Moderators:

Natalie Wuliji, DO

Panelists:

Saurabh Dahiya, MD; Hans-Peter Kiem, PhD

02:30 PM - 02:45 PMBreak & Exhibits
02:45 PM - 03:45 PMLeukemia and Transplant

Session Chair: Filippo Milano, MD

02:45 PM - 03:00 PM

Immunotherapy for Myeloid Malignancies — Challenges and Promises Hany Elmariah

03:00 PM - 03:15 PM

Cellular Therapy in Allogeneic Transplant (Orca-T, Omidubicel and Beyond) Filippo Milano, MD

03:15 PM - 03:30 PM

ALL — Focus on Immunotherapeutic Approaches, Approved and Investigational Options Ryan Cassaday, MD

03:30 PM - 03:45 PM

Panel Discussion

Moderators:

Filippo Milano, MD

Panelists:

Hany Elmariah ; Ryan Cassaday, MD

03:45 PM - 04:45 PMChronic Lymphocytic Leukemia

Session Chair: Alexey Danilov, MD

03:45 PM - 04:00 PM

Immunotherapy (CAR-T and Bispecific Antibodies) for CLL Bita Fakhri, MD, MPH

04:00 PM - 04:15 PM

How Will CLL Be Treated in 2030? Alexey Danilov, MD

04:15 PM - 04:45 PM

Panel Discussion

Moderators:

Alexey Danilov, MD

Panelists:

Bita Fakhri, MD, MPH

Day 2: Saturday, August 15th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits
08:00 AM - 09:30 AMTopics in T-Cell Engaging Therapies

Session Chair: Mazyar Shadman, MD

08:00 AM - 08:15 AM

Barriers to CAR-T Use — Challenges and Opportunities Mazyar Shadman, MD

08:15 AM - 08:30 AM

Bispecific Antibodies in Community Setting — General Principles Sibel Blau, MD

08:30 AM - 08:45 AM

Next-Generation T-Cell Engagers Krish Patel

08:45 AM - 09:00 AM

State of Cellular Immunotherapy in 2030 Matthew Alexander Lunning, DO

09:00 AM - 09:30 AM

Panel Discussion

Moderators:

Mazyar Shadman, MD

Panelists:

Sibel Blau, MD; Krish Patel ; Matthew Alexander Lunning, DO

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship